tert-Butyl (chloromethyl) succinate

Catalog No. :
ACNQSP379
CAS No. :
432037-43-9
Molecular Formula :
C9H15ClO4
Molecular Weight :
222.67

IUPAC Name:tert-butyl (chloromethyl) succinate

tert-Butyl (chloromethyl) succinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$103.00Login to see priceIn stockInquiry
5g95%$415.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (chloromethyl) succinate
IUPAC Nametert-butyl (chloromethyl) succinate
MDL No.MFCD13194872
Molecular FormulaC9H15ClO4
Molecular Weight222.67
SMILESO(C(C)(C)C)C(=O)CCC(=O)OCCl
InChI KeyZEHMWPBRDVLBMH-UHFFFAOYSA-N
SynonymButanedioic, 1-(chloromethyl)-4-t-butyl ester;Butanedioic acid 1-chloromethyl 4-tert-butyl ester;Chloromethyl tert-butyl succinate;CL208;Butanedioic acid, 1-(chloromethyl) 4-(1,1-dimethylethyl) ester;4-O-tert-butyl 1-O-(chloromethyl) butanedioate;1-Chloromethyl-4-tert-butylsuccinic acid
CAS No.432037-43-9
PubChem CID18629482

Safety Data

Pictogram
Corrosive
Signal Word
Gefahr
Hazard Statement(s)
H314
Precautionary Statement(s)
P260-P264-P280-P301+P310+P330+P331-P303+P361+P353+P310-P304+P340+P310-P305+P351+P338+P310-P363-P405-P501

Synthetic Route by SureRoute

1. ACNQSP379 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGBDX213 route compound structure diagram
    ACGBDX21315026-17-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNQSP379 route product structure diagram
    ACNQSP379432037-43-9 In Stock
Inquiry

2. ACNQSP379 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGBDX213 route compound structure diagram
    ACGBDX21315026-17-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNQSP379 route product structure diagram
    ACNQSP379432037-43-9 In Stock
Inquiry

Comments (0)